Medacta announced the first surgery using its MOTO Lateral Partial Knee system, which recently received CE Mark approval and FDA 510(k) clearance.
MOTO Lateral is a compartment-specific, fixed-bearing implant for the treatment of osteoarthritis on the lateral femoral and tibial condyles. This device is part of the MOTO Partial Knee System, which also includes MOTO Medial (launched in 2017 and shown above) and MOTO PFJ, a new Patello-Femoral Joint implant that will be available at the beginning of 2021.
MOTO offers a range of options to resurface only the affected portion of the patient's knee. All MOTO components feature an anatomic and compartment-specific design, based on Medacta's MyBody anthropometric database, comprising more than 45,000 CT and MRI knee scans.
MOTO PFJ will treat patellofemoral osteoarthritis without compromising non-affected tibiofemoral knee compartments. This implant will feature an onlay-anterior and inlay-distal design with a broad-anterior and narrow-distal shape to restore painless patellar movement throughout the whole articular range of motion.